Cocrystal Pharma Inc logo

Cocrystal Pharma Inc

NAS:COCP (USA)  
$ 1.40 -0.1 (-6.67%) 07:08 PM EST
At Loss
P/B:
0.46
Market Cap:
$ 14.24M
Enterprise V:
$ -14.36M
Volume:
82.84K
Avg Vol (2M):
11.55K
Also Trade In:
Volume:
82.84K
At Loss
Avg Vol (2M):
11.55K

Business Description

Description
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Name Current Vs Industry Vs History
Cash-To-Debt 252.02
Equity-to-Asset 0.94
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 51.91
9-Day RSI 51.19
14-Day RSI 49.71
6-1 Month Momentum % -26.05
12-1 Month Momentum % -21.65

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.74
Quick Ratio 16.74
Cash Ratio 15.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -40.6
Shareholder Yield % 1.58

Financials (Next Earnings Date:2024-03-29 Est.)

COCP's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:COCP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cocrystal Pharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2
Beta 1.12
Volatility % 57.48
14-Day RSI 49.71
14-Day ATR ($) 0.089647
20-Day SMA ($) 1.4889
12-1 Month Momentum % -21.65
52-Week Range ($) 1.325 - 3.285
Shares Outstanding (Mil) 10.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cocrystal Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

Cocrystal Pharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cocrystal Pharma Inc Frequently Asked Questions

What is Cocrystal Pharma Inc(COCP)'s stock price today?
The current price of COCP is $1.40. The 52 week high of COCP is $3.29 and 52 week low is $1.33.
When is next earnings date of Cocrystal Pharma Inc(COCP)?
The next earnings date of Cocrystal Pharma Inc(COCP) is 2024-03-29 Est..
Does Cocrystal Pharma Inc(COCP) pay dividends? If so, how much?
Cocrystal Pharma Inc(COCP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1